Aptar Digital Health announced that the FDA has granted 510(k) clearance for HeroTracker Sense as a Class II medical device.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATR:
- AptarGroup price target lowered to $167 from $175 at BofA
- Nasus Pharma announces expanded agreement to support NS002
- AptarGroup’s Strategic Shift to Pharma Drives Buy Rating Amid Profitability Gains
- AptarGroup price target lowered to $152 from $153 at Wells Fargo
- AptarGroup: Balancing Long-Term Potential with Short-Term Challenges – Hold Rating